Skip to main content
Top
Published in: Abdominal Radiology 3/2013

Open Access 01-06-2013

Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI

Authors: C. S. van Kessel, E. de Boer, F. J. W. ten Kate, L. A. A. Brosens, W. B. Veldhuis, M. S. van Leeuwen

Published in: Abdominal Radiology | Issue 3/2013

Login to get access

Abstract

Objectives

To assess the range of hepatobiliary enhancement patterns of focal nodular hyperplasia (FNH) after gadoxetic-acid injection, and to correlate these patterns to specific histological features.

Materials and methods

FNH lesions, imaged with Gadoxetic-acid-enhanced MRI, with either typical imaging findings on T1, T2 and dynamic-enhanced sequences or histologically proven, were evaluated for hepatobiliary enhancement patterns and categorized as homogeneously hyperintense, inhomogeneously hyperintense, iso-intense, or hypo-intense-with-ring. Available histological specimens of FNHs (surgical resection or histological biopsy), were re-evaluated to correlate histological features with observed enhancement patterns.

Results

26 FNHs in 20 patients were included; histology was available in six lesions (four resections, two biopsies). The following distribution of enhancement patterns was observed: 10/26 homogeneously hyperintense, 4/26 inhomogeneously hyperintense, 5/26 iso-intense, 6/26 hypointense-with-ring, and 1/26 hypointense, but without enhancing ring. The following histological features associated with gadoxetic-acid uptake were identified: number and type of bile-ducts (pre-existent bile-ducts, proliferation, and metaplasia), extent of fibrosis, the presence of inflammation and extent of vascular proliferation.

Conclusion

FNH lesions can be categorized into different hepatobiliary enhancement patterns on Gadoxetic-acid-enhanced MRI, which appear to be associated with histological differences in number and type of bile-ducts, and varying the presence of fibrous tissue, inflammation, and vascularization.
Literature
1.
go back to reference Buell JF, Tranchart H, Cannon R, Dagher I (2010) Management of benign hepatic tumors. Surg Clin North Am 90:719–735PubMedCrossRef Buell JF, Tranchart H, Cannon R, Dagher I (2010) Management of benign hepatic tumors. Surg Clin North Am 90:719–735PubMedCrossRef
2.
go back to reference Ishak KG, Goodman ZD, Stocker JT (2001) Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology Ishak KG, Goodman ZD, Stocker JT (2001) Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology
3.
go back to reference Kerlin P, Davis GL, McGill DB, et al. (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84:994–1002PubMed Kerlin P, Davis GL, McGill DB, et al. (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84:994–1002PubMed
4.
go back to reference Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454PubMedCrossRef Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454PubMedCrossRef
5.
go back to reference Kondo F, Nagao T, Sato T, et al. (1998) Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 194:487–495PubMedCrossRef Kondo F, Nagao T, Sato T, et al. (1998) Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 194:487–495PubMedCrossRef
6.
go back to reference Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194–1200PubMedCrossRef Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194–1200PubMedCrossRef
7.
go back to reference Butron VMM, Haot J, Desmet VJ (1984) Cholestatic features in focal nodular hyperplasia. Liver 4:387–395 Butron VMM, Haot J, Desmet VJ (1984) Cholestatic features in focal nodular hyperplasia. Liver 4:387–395
8.
go back to reference van Eyken P, Sciot R, Callea F, Desmet VJ (1989) A cytokeratin-immunohistochemical study of focal nodular hyperplasia of the liver: further evidence that ductular metaplasia of hepatocytes contributes to ductular “proliferation”. Liver 9:372–377PubMed van Eyken P, Sciot R, Callea F, Desmet VJ (1989) A cytokeratin-immunohistochemical study of focal nodular hyperplasia of the liver: further evidence that ductular metaplasia of hepatocytes contributes to ductular “proliferation”. Liver 9:372–377PubMed
9.
go back to reference Weimann A, Ringe B, Klempnauer J, et al. (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21:983–990PubMedCrossRef Weimann A, Ringe B, Klempnauer J, et al. (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21:983–990PubMedCrossRef
10.
go back to reference Bartolotta TV, Midiri M, Scialpi M, et al. (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591PubMedCrossRef Bartolotta TV, Midiri M, Scialpi M, et al. (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591PubMedCrossRef
11.
go back to reference Bartolotta TV, Midiri M, Quaia E, et al. (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedCrossRef Bartolotta TV, Midiri M, Quaia E, et al. (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedCrossRef
12.
go back to reference Bartolotta TV, Taibbi A, Matranga D, et al. (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20:2248–2256PubMedCrossRef Bartolotta TV, Taibbi A, Matranga D, et al. (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20:2248–2256PubMedCrossRef
13.
go back to reference Herman P, Pugliese V, Machado MA, et al. (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24:372–376PubMedCrossRef Herman P, Pugliese V, Machado MA, et al. (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24:372–376PubMedCrossRef
14.
go back to reference Hussain SM, Terkivatan T, van Zonder PE, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17PubMedCrossRef Hussain SM, Terkivatan T, van Zonder PE, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17PubMedCrossRef
15.
go back to reference Mortele KJ, Praet M, Van VH, et al. (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27:700–707PubMedCrossRef Mortele KJ, Praet M, Van VH, et al. (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27:700–707PubMedCrossRef
16.
go back to reference Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J (1994) Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 19:34–38PubMedCrossRef Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J (1994) Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 19:34–38PubMedCrossRef
17.
go back to reference Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef
18.
go back to reference Ba-Ssalamah A, Schima W, Schmook MT, et al. (2002) Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179:1447–1456PubMedCrossRef Ba-Ssalamah A, Schima W, Schmook MT, et al. (2002) Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179:1447–1456PubMedCrossRef
19.
go back to reference Choi CS, Freeny PC (1998) Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 170:391–395PubMedCrossRef Choi CS, Freeny PC (1998) Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 170:391–395PubMedCrossRef
20.
go back to reference Uggowitzer MM, Kugler C, Ruppert-Kohlmayr A, et al. (2000) Current status of diagnostic imaging of focal nodular hyperplasia of the liver. Rofo 172:727–738PubMedCrossRef Uggowitzer MM, Kugler C, Ruppert-Kohlmayr A, et al. (2000) Current status of diagnostic imaging of focal nodular hyperplasia of the liver. Rofo 172:727–738PubMedCrossRef
21.
go back to reference Vilgrain V, Flejou JF, Arrive L, et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703PubMed Vilgrain V, Flejou JF, Arrive L, et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703PubMed
22.
go back to reference Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed
23.
go back to reference Tsuboyama T, Onishi H, Kim T, et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833PubMedCrossRef Tsuboyama T, Onishi H, Kim T, et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833PubMedCrossRef
24.
go back to reference Kondo F (2001) Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 16:1319–1328PubMedCrossRef Kondo F (2001) Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 16:1319–1328PubMedCrossRef
25.
go back to reference Slott PA, Liu MH, Tavoloni N (1990) Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 99:466–477PubMed Slott PA, Liu MH, Tavoloni N (1990) Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 99:466–477PubMed
Metadata
Title
Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI
Authors
C. S. van Kessel
E. de Boer
F. J. W. ten Kate
L. A. A. Brosens
W. B. Veldhuis
M. S. van Leeuwen
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9916-0

Other articles of this Issue 3/2013

Abdominal Radiology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.